Skip to main content

Advertisement

SpringerLink
Log in

Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pui CH and Evans WE (2006) Drug therapy: treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166–178

    Article  CAS  Google Scholar 

  2. Attal M et al. (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495–2502

    Article  CAS  Google Scholar 

  3. Abdelkefi A et al. (2007) Single autologous stem cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial. Blood [doi:10.1182/blood-2007-07-101212]

  4. Shaughnessy JD Jr et al. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109: 2276–2284

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA vanrheefrits@uams.edu

Authors and Affiliations

  1. F van Rhee is Director of Clinical Research at the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.,

    Frits van Rhee

Authors
  1. Frits van Rhee
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Rhee, F. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?. Nat Rev Clin Oncol 5, 70–71 (2008). https://doi.org/10.1038/ncponc1005

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1005

  • Springer Nature Limited

Search

Navigation